The complex interactions among serotonin, insulin, leptin, and glycolipid metabolic parameters in human obesity

To provide evidence to the link between serotonin (5-HT), energy metabolism, and the human obese phenotype, the present study investigated the binding and function of the platelet 5-HT transporter (SERT), in relation to circulating insulin, leptin, and glycolipid metabolic parameters. Seventy-four d...

Full description

Saved in:
Bibliographic Details
Published inCNS spectrums Vol. 27; no. 1; pp. 99 - 108
Main Authors Marazziti, Donatella, Betti, Laura, Baroni, Stefano, Palego, Lionella, Mucci, Federico, Carpita, Barbara, Cremone, Ivan Mirco, Santini, Ferruccio, Fabbrini, Laura, Pelosini, Caterina, Marsili, Alessandro, Massimetti, Enrico, Giannaccini, Gino, Dell’Osso, Liliana
Format Journal Article
LanguageEnglish
Published New York, USA Cambridge University Press 01.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To provide evidence to the link between serotonin (5-HT), energy metabolism, and the human obese phenotype, the present study investigated the binding and function of the platelet 5-HT transporter (SERT), in relation to circulating insulin, leptin, and glycolipid metabolic parameters. Seventy-four drug-free subjects were recruited on the basis of divergent body mass index (BMIs) (16.5-54.8 Kg/m2). All subjects were tested for their blood glycolipid profile together with platelet [3H]-paroxetine ([3H]-Par) binding and [3H]-5-HT reuptake measurements from April 1st to June 30th, 2019. The [3H]-Par Bmax (fmol/mg proteins) was progressively reduced with increasing BMIs (P < .001), without changes in affinity. Moreover, Bmax was negatively correlated with BMI, waist/hip circumferences (W/HC), triglycerides (TD), glucose, insulin, and leptin, while positively with high-density lipoprotein (HDL) cholesterol (P < .01). The reduction of 5-HT uptake rate (Vmax, pmol/min/109 platelets) among BMI groups was not statistically significant, but Vmax negatively correlated with leptin and uptake affinity values (P < .05). Besides, [3H]-Par affinity values positively correlated with glycemia and TD, while [3H]-5-HT reuptake affinity with glycemia only (P < .05). Finally, these correlations were specific of obese subjects, while, from multiple linear-regression analysis conducted on all subjects, insulin (P = .006) resulting negatively related to Bmax independently from BMI. Present findings suggest the presence of a possible alteration of insulin/5-HT/leptin axis in obesity, differentially impinging the density, function, and/or affinity of the platelet SERT, as a result of complex appetite/reward-related interactions between the brain, gut, pancreatic islets, and adipose tissue. Furthermore, they support the foremost cooperation of peptides and 5-HT in maintaining energy homeostasis.
AbstractList To provide evidence to the link between serotonin (5-HT), energy metabolism, and the human obese phenotype, the present study investigated the binding and function of the platelet 5-HT transporter (SERT), in relation to circulating insulin, leptin, and glycolipid metabolic parameters. Seventy-four drug-free subjects were recruited on the basis of divergent body mass index (BMIs) (16.5-54.8 Kg/m2). All subjects were tested for their blood glycolipid profile together with platelet [3H]-paroxetine ([3H]-Par) binding and [3H]-5-HT reuptake measurements from April 1st to June 30th, 2019. The [3H]-Par Bmax (fmol/mg proteins) was progressively reduced with increasing BMIs (P < .001), without changes in affinity. Moreover, Bmax was negatively correlated with BMI, waist/hip circumferences (W/HC), triglycerides (TD), glucose, insulin, and leptin, while positively with high-density lipoprotein (HDL) cholesterol (P < .01). The reduction of 5-HT uptake rate (Vmax, pmol/min/109 platelets) among BMI groups was not statistically significant, but Vmax negatively correlated with leptin and uptake affinity values (P < .05). Besides, [3H]-Par affinity values positively correlated with glycemia and TD, while [3H]-5-HT reuptake affinity with glycemia only (P < .05). Finally, these correlations were specific of obese subjects, while, from multiple linear-regression analysis conducted on all subjects, insulin (P = .006) resulting negatively related to Bmax independently from BMI. Present findings suggest the presence of a possible alteration of insulin/5-HT/leptin axis in obesity, differentially impinging the density, function, and/or affinity of the platelet SERT, as a result of complex appetite/reward-related interactions between the brain, gut, pancreatic islets, and adipose tissue. Furthermore, they support the foremost cooperation of peptides and 5-HT in maintaining energy homeostasis.
ObjectiveTo provide evidence to the link between serotonin (5-HT), energy metabolism, and the human obese phenotype, the present study investigated the binding and function of the platelet 5-HT transporter (SERT), in relation to circulating insulin, leptin, and glycolipid metabolic parameters.MethodsSeventy-four drug-free subjects were recruited on the basis of divergent body mass index (BMIs) (16.5-54.8 Kg/m2). All subjects were tested for their blood glycolipid profile together with platelet [3H]-paroxetine ([3H]-Par) binding and [3H]-5-HT reuptake measurements from April 1st to June 30th, 2019.ResultsThe [3H]-Par Bmax (fmol/mg proteins) was progressively reduced with increasing BMIs (P < .001), without changes in affinity. Moreover, Bmax was negatively correlated with BMI, waist/hip circumferences (W/HC), triglycerides (TD), glucose, insulin, and leptin, while positively with high-density lipoprotein (HDL) cholesterol (P < .01). The reduction of 5-HT uptake rate (Vmax, pmol/min/109 platelets) among BMI groups was not statistically significant, but Vmax negatively correlated with leptin and uptake affinity values (P < .05). Besides, [3H]-Par affinity values positively correlated with glycemia and TD, while [3H]-5-HT reuptake affinity with glycemia only (P < .05). Finally, these correlations were specific of obese subjects, while, from multiple linear-regression analysis conducted on all subjects, insulin (P = .006) resulting negatively related to Bmax independently from BMI.ConclusionsPresent findings suggest the presence of a possible alteration of insulin/5-HT/leptin axis in obesity, differentially impinging the density, function, and/or affinity of the platelet SERT, as a result of complex appetite/reward-related interactions between the brain, gut, pancreatic islets, and adipose tissue. Furthermore, they support the foremost cooperation of peptides and 5-HT in maintaining energy homeostasis.
Abstract Objective To provide evidence to the link between serotonin (5-HT), energy metabolism, and the human obese phenotype, the present study investigated the binding and function of the platelet 5-HT transporter (SERT), in relation to circulating insulin, leptin, and glycolipid metabolic parameters. Methods Seventy-four drug-free subjects were recruited on the basis of divergent body mass index (BMIs) (16.5-54.8 Kg/m 2 ). All subjects were tested for their blood glycolipid profile together with platelet [ 3 H]-paroxetine ([ 3 H]-Par) binding and [ 3 H]-5-HT reuptake measurements from April 1st to June 30th, 2019. Results The [ 3 H]-Par B max (fmol/mg proteins) was progressively reduced with increasing BMIs ( P  < .001), without changes in affinity. Moreover, B max was negatively correlated with BMI, waist/hip circumferences (W/HC), triglycerides (TD), glucose, insulin, and leptin, while positively with high-density lipoprotein (HDL) cholesterol ( P  < .01). The reduction of 5-HT uptake rate ( V max , pmol/min/10 9 platelets) among BMI groups was not statistically significant, but V max negatively correlated with leptin and uptake affinity values ( P  < .05). Besides, [ 3 H]-Par affinity values positively correlated with glycemia and TD, while [ 3 H]-5-HT reuptake affinity with glycemia only ( P  < .05). Finally, these correlations were specific of obese subjects, while, from multiple linear-regression analysis conducted on all subjects, insulin ( P  = .006) resulting negatively related to B max independently from BMI. Conclusions Present findings suggest the presence of a possible alteration of insulin/5-HT/leptin axis in obesity, differentially impinging the density, function, and/or affinity of the platelet SERT, as a result of complex appetite/reward-related interactions between the brain, gut, pancreatic islets, and adipose tissue. Furthermore, they support the foremost cooperation of peptides and 5-HT in maintaining energy homeostasis.
Author Betti, Laura
Palego, Lionella
Carpita, Barbara
Santini, Ferruccio
Baroni, Stefano
Marazziti, Donatella
Cremone, Ivan Mirco
Pelosini, Caterina
Dell’Osso, Liliana
Marsili, Alessandro
Giannaccini, Gino
Fabbrini, Laura
Massimetti, Enrico
Mucci, Federico
Author_xml – sequence: 1
  givenname: Donatella
  orcidid: 0000-0002-4021-5829
  surname: Marazziti
  fullname: Marazziti, Donatella
  email: dmarazzi@psico.med.unipi.it
  organization: 1Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Italy
– sequence: 2
  givenname: Laura
  surname: Betti
  fullname: Betti, Laura
  organization: 4Department of Pharmacy, University of Pisa, Italy
– sequence: 3
  givenname: Stefano
  surname: Baroni
  fullname: Baroni, Stefano
  organization: 1Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Italy
– sequence: 4
  givenname: Lionella
  surname: Palego
  fullname: Palego, Lionella
  organization: 4Department of Pharmacy, University of Pisa, Italy
– sequence: 5
  givenname: Federico
  orcidid: 0000-0002-9746-8237
  surname: Mucci
  fullname: Mucci, Federico
  organization: 1Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Italy
– sequence: 6
  givenname: Barbara
  orcidid: 0000-0002-2806-6736
  surname: Carpita
  fullname: Carpita, Barbara
  organization: 1Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Italy
– sequence: 7
  givenname: Ivan Mirco
  surname: Cremone
  fullname: Cremone, Ivan Mirco
  organization: 1Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Italy
– sequence: 8
  givenname: Ferruccio
  surname: Santini
  fullname: Santini, Ferruccio
  organization: 6Department of Clinical and Experimental Medicine, Endocrinology Unit, Obesity and Lipodystrophy Centre, University of Pisa, Pisa, Italy
– sequence: 9
  givenname: Laura
  surname: Fabbrini
  fullname: Fabbrini, Laura
  organization: 7Pharmacology and Pharmacogenetics, University Hospital Unit, University of Pisa, Pisa, Italy
– sequence: 10
  givenname: Caterina
  surname: Pelosini
  fullname: Pelosini, Caterina
  organization: 6Department of Clinical and Experimental Medicine, Endocrinology Unit, Obesity and Lipodystrophy Centre, University of Pisa, Pisa, Italy
– sequence: 11
  givenname: Alessandro
  surname: Marsili
  fullname: Marsili, Alessandro
  organization: 6Department of Clinical and Experimental Medicine, Endocrinology Unit, Obesity and Lipodystrophy Centre, University of Pisa, Pisa, Italy
– sequence: 12
  givenname: Enrico
  surname: Massimetti
  fullname: Massimetti, Enrico
  organization: 8 ASST, «Servizio Psichiatrico Diagnosi e Cura», Hospital of “Bergamo Ovest”, SSD, Treviglio, Italy
– sequence: 13
  givenname: Gino
  surname: Giannaccini
  fullname: Giannaccini, Gino
  organization: 4Department of Pharmacy, University of Pisa, Italy
– sequence: 14
  givenname: Liliana
  surname: Dell’Osso
  fullname: Dell’Osso, Liliana
  organization: 1Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32921339$$D View this record in MEDLINE/PubMed
BookMark eNp1UEtLxDAQDrLiPvQHeJGAV6tJ0zbpURZfsODB9VwmabrbpU1q0oL7703ZVQ_iaWb4Xsw3RxNjjUbokpJbSii_e6Mkj0Ua5zEhhIqYnKBZTLM0ylKST9BshKMRn6K59ztCEsYFO0NTFiSUsXyG7HqrsbJt1-hPXJteO1B9bY3H0FqzwV4721tTm5uA-qEZl0Z3_TjBlHjT7JVt6q4ucat7kGFXuAMH4dLOBxHeDi0YbKX2db8_R6cVNF5fHOcCvT8-rJfP0er16WV5v4oU46yPmMohZqkAXlap4kKEB0VFJSQiyVh4FzJIQcqMkVyrElIlucpyDkLJQCJsga4Pvp2zH4P2fbGzgzMhsoh5muQi4VQEFj2wlLPeO10VnatbcPuCkmKsuPhTcdBcHZ0H2eryR_HdaSCwoym00tXlRv9m_2_7BQxpiPk
CitedBy_id crossref_primary_10_1210_clinem_dgac078
crossref_primary_10_3390_life11040313
crossref_primary_10_3389_fendo_2022_927576
crossref_primary_10_1016_j_euroneuro_2021_10_287
crossref_primary_10_22141_2224_0721_19_5_2023_1299
Cites_doi 10.1056/NEJM199602013340503
10.1007/s11064-009-0112-8
10.1016/S0140-6736(17)32366-8
10.1111/apha.13101
10.1093/nutrit/nuy070
10.1007/7854_2012_211
10.1007/s40273-014-0243-x
10.1210/en.2016-1839
10.1016/0160-5402(85)90034-8
10.1016/j.neuropharm.2016.08.015
10.1016/S0165-1781(01)00281-5
10.1038/nrcardio.2010.222
10.3109/10799898709054999
10.1186/1471-2202-14-128
10.1172/JCI70338
10.1159/000119308
10.1016/j.atherosclerosis.2011.06.045
10.1016/0165-1781(82)90022-1
10.1093/bmb/ldu001
10.1146/annurev-psych-010418-102936
10.1016/j.coph.2007.10.010
10.1371/journal.pbio.1000229
10.1002/erv.2303
10.1001/jama.282.16.1568
10.1084/jem.20101940
10.1016/S0165-6147(00)01514-5
10.1111/j.1463-1326.2011.01378.x
10.1016/j.neuroimage.2010.03.086
10.1007/s11684-013-0263-5
10.1016/j.nutres.2012.03.009
10.3389/fendo.2019.00158
10.3389/fncel.2017.00277
10.1007/s11011-008-9118-1
10.1186/1471-2202-12-18
10.1001/archpsyc.1977.01770170019001
10.1113/jphysiol.2008.164152
10.3389/fnins.2017.00493
10.1017/S1092852913000667
10.1155/2010/748048
10.1074/jbc.271.28.16494
10.1017/S0007114508076204
10.1016/j.biopsych.2013.01.032
10.1007/s13679-015-0169-4
10.1007/s00726-012-1330-y
10.1016/j.bbr.2014.08.065
10.1371/journal.pone.0078241
10.1074/jbc.M603877200
10.1007/BF03159915
10.2337/db10-1192
10.1016/j.tem.2011.04.006
10.1210/er.2018-00283
10.1016/j.biopsych.2015.10.023
10.1111/j.1471-4159.1993.tb03522.x
10.1016/S0893-133X(97)00204-2
10.1210/me.2010-0054
10.1111/j.1749-6632.2002.tb04293.x
10.2174/1389450111314050003
10.1016/j.tics.2010.11.001
10.1016/j.febslet.2015.05.054
10.2174/1570159X15666171123201142
10.2174/157339508784325046
10.4103/jpgm.JPGM_712_16
10.1111/j.1749-6632.1990.tb16907.x
10.1016/j.pharmthera.2011.03.013
10.1016/j.jad.2019.11.092
10.1016/j.neulet.2012.01.038
10.1016/S0165-0327(97)00074-8
10.1016/j.ejphar.2011.07.005
10.1371/journal.pone.0187448
ContentType Journal Article
Copyright The Author(s), 2020. Published by Cambridge University Press
Copyright_xml – notice: The Author(s), 2020. Published by Cambridge University Press
DBID NPM
AAYXX
CITATION
3V.
7X7
7XB
88G
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9.
M0S
M2M
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
DOI 10.1017/S1092852920001820
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Psychology Database (Alumni)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Psychology Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
DatabaseTitle PubMed
CrossRef
ProQuest One Psychology
ProQuest Central Student
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList PubMed
ProQuest One Psychology
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2165-6509
EndPage 108
ExternalDocumentID 10_1017_S1092852920001820
32921339
Genre Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GroupedDBID ---
-E.
.GJ
09C
09E
0E1
0R~
123
29B
36B
53G
5VS
6PF
7X7
8FI
8FJ
AAAZR
AABES
AABWE
AACJH
AAEED
AAGFV
AAKTX
AARAB
AASVR
AAUKB
AAWTL
ABBXD
ABBZL
ABGDZ
ABJNI
ABKKG
ABMYL
ABQTM
ABROB
ABUWG
ABWCF
ABXAU
ABZCX
ABZUI
ACBMC
ACCHT
ACETC
ACGFO
ACGFS
ACIMK
ACQFJ
ACREK
ACUIJ
ACUYZ
ACWGA
ACYZP
ACZBM
ACZUX
ADAZD
ADDNB
ADFEC
ADGEJ
ADKIL
ADOCW
ADOVH
ADOVT
ADVJH
AEBAK
AEBPU
AEHGV
AENCP
AENEX
AENGE
AEPLO
AEYHU
AEYYC
AFFUJ
AFKQG
AFKRA
AFLOS
AFLVW
AFUTZ
AGABE
AGJUD
AGLWM
AGOOT
AHIPN
AHLTW
AHQXX
AHRGI
AIGNW
AIHIV
AIOIP
AISIE
AJCYY
AJPFC
AJQAS
AKZCZ
ALMA_UNASSIGNED_HOLDINGS
ANPSP
AQJOH
ARABE
ARZZG
ATUCA
AUXHV
AYIQA
AZGZS
AZQEC
BBLKV
BCGOX
BENPR
BESQT
BGHMG
BJBOZ
BLZWO
BMAJL
BQFHP
BRIRG
C0O
C1A
C45
CBIIA
CCPQU
CCQAD
CCUQV
CFAFE
CFBFF
CGQII
CHEAL
CJCSC
DC4
DOHLZ
DWQXO
E3Z
EBS
EGQIC
EJD
EMB
EMOBN
F5P
FYUFA
GNUQQ
HG-
HMCUK
HZ~
I.6
I.7
I.9
IH6
IOEEP
IOO
IS6
I~P
JHPGK
JQKCU
JVRFK
KAFGG
KCGVB
KFECR
LHUNA
LW7
M-V
M2M
NIKVX
NZEOI
O9-
OHT
OK1
OVD
P2P
PSYQQ
RCA
ROL
RR0
S6-
S6U
SAAAG
SJN
SV3
SY4
T9M
TEORI
TR2
UKHRP
UT1
UU6
WFFJZ
WXY
ZDLDU
ZJOSE
ZMEZD
ZYDXJ
ABVZP
ALIPV
CTKSN
NPM
AAYXX
CITATION
3V.
7XB
8FK
K9.
PQEST
PQQKQ
PQUKI
PRINS
Q9U
ID FETCH-LOGICAL-c373t-3c9a2358a7df5c7880008f1ba48463200a6a5abb6309ecda5cb7c697a8cbba403
IEDL.DBID 7X7
ISSN 1092-8529
IngestDate Thu Oct 10 15:46:19 EDT 2024
Thu Sep 26 18:14:07 EDT 2024
Sat Sep 28 08:41:10 EDT 2024
Wed Mar 13 06:06:10 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Obesity
serotonin
insulin
glycolipid metabolism
serotonin transporter
leptin
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c373t-3c9a2358a7df5c7880008f1ba48463200a6a5abb6309ecda5cb7c697a8cbba403
ORCID 0000-0002-9746-8237
0000-0002-4021-5829
0000-0002-2806-6736
PMID 32921339
PQID 2754984718
PQPubID 5528237
PageCount 10
ParticipantIDs proquest_journals_2754984718
crossref_primary_10_1017_S1092852920001820
pubmed_primary_32921339
cambridge_journals_10_1017_S1092852920001820
PublicationCentury 2000
PublicationDate 2022-02-01
PublicationDateYYYYMMDD 2022-02-01
PublicationDate_xml – month: 02
  year: 2022
  text: 2022-02-01
  day: 01
PublicationDecade 2020
PublicationPlace New York, USA
PublicationPlace_xml – name: New York, USA
– name: United States
– name: New York
PublicationTitle CNS spectrums
PublicationTitleAlternate CNS Spectr
PublicationYear 2022
Publisher Cambridge University Press
Publisher_xml – name: Cambridge University Press
References 1990; 13
2017; 81
2015; 589
1993; 60
2019; 10
2011; 60
2015; 33
1987; 7
2013; 123
2017; 390
2016; 2017
2011; 13
2011; 12
2011; 15
2008; 4
2013; 7
2013; 8
2017; 158
2014; 22
2001; 103
1996; 34
2011; 208
2013; 14
1998; 19
2010; 24
1982; 6
2011; 22
2016; 110
2007; 7
2014; 19
1998; 50
1977; 34
2006; 281
1996; 334
1985; 14
2017; 63
2009; 24
1990; 600
2012; 220
2019; 70
2015; 4
2010; 2010
2010; 35
2019; 77
2013; 45
2000; 21
2019; 225
2020; 265
2012; 32
2011; 8
2011; 131
2014; 109
2011; 668
2019; 40
2015; 277
2017; 11
2013; 73
1999; 282
2017; 12
1996; 271
2009; 101
2009; 7
2002; 967
2012; 511
2009; 587
2010; 52
2018; 16
2016; 22
S1092852920001820_r36
S1092852920001820_r37
S1092852920001820_r38
S1092852920001820_r39
S1092852920001820_r72
S1092852920001820_r73
S1092852920001820_r30
S1092852920001820_r74
S1092852920001820_r31
S1092852920001820_r32
S1092852920001820_r34
S1092852920001820_r35
First (S1092852920001820_r33) 1997
S1092852920001820_r47
S1092852920001820_r49
S1092852920001820_r40
S1092852920001820_r41
S1092852920001820_r42
S1092852920001820_r43
S1092852920001820_r44
S1092852920001820_r45
S1092852920001820_r46
S1092852920001820_r58
S1092852920001820_r14
S1092852920001820_r59
S1092852920001820_r15
Apovian (S1092852920001820_r2) 2016; 22
S1092852920001820_r16
S1092852920001820_r17
S1092852920001820_r18
S1092852920001820_r19
S1092852920001820_r50
S1092852920001820_r51
S1092852920001820_r52
S1092852920001820_r53
S1092852920001820_r10
S1092852920001820_r54
S1092852920001820_r11
S1092852920001820_r55
S1092852920001820_r56
S1092852920001820_r12
S1092852920001820_r13
S1092852920001820_r57
S1092852920001820_r60
S1092852920001820_r69
S1092852920001820_r25
S1092852920001820_r26
S1092852920001820_r27
S1092852920001820_r28
S1092852920001820_r29
Hales (S1092852920001820_r4) 2016; 2017
S1092852920001820_r1
S1092852920001820_r61
S1092852920001820_r62
S1092852920001820_r63
S1092852920001820_r3
S1092852920001820_r64
S1092852920001820_r20
S1092852920001820_r21
S1092852920001820_r65
S1092852920001820_r22
S1092852920001820_r66
S1092852920001820_r23
S1092852920001820_r67
S1092852920001820_r24
S1092852920001820_r68
S1092852920001820_r9
S1092852920001820_r5
S1092852920001820_r6
S1092852920001820_r70
S1092852920001820_r7
S1092852920001820_r8
S1092852920001820_r71
Rajan (S1092852920001820_r48) 2017; 63
References_xml – volume: 225
  start-page: e13101
  issue: 1
  year: 2019
  article-title: Serotonergic regulation of insulin secretion
  publication-title: Acta Physiol (Oxf)
– volume: 7
  start-page: e1000229
  issue: 10
  year: 2009
  article-title: Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation
  publication-title: PLoS Biol
– volume: 40
  start-page: 1092
  issue: 4
  year: 2019
  end-page: 1107
  article-title: Emerging roles for serotonin in regulating metabolism: new implications for an ancient molecule
  publication-title: Endocr Rev
– volume: 123
  start-page: 5061
  issue: 12
  year: 2013
  end-page: 5070
  article-title: Serotonin 2C receptors in pro-opiomelanocortin neurons regulate energy and glucose homeostasis [published correction appears in J Clin Invest. 2014;124(4):1868. Dosage error in article text]
  publication-title: J Clin Invest
– volume: 14
  start-page: 128
  year: 2013
  article-title: The expression of platelet serotonin transporter (SERT) in human obesity
  publication-title: BMC Neurosci
– volume: 32
  start-page: 309
  issue: 5
  year: 2012
  end-page: 319
  article-title: Diet promotes sleep duration and quality
  publication-title: Nutr Res
– volume: 110
  start-page: 438
  issue: A
  year: 2016
  end-page: 448
  article-title: An interplay between the serotonin transporter (SERT) and 5-HT receptors controls stimulus-secretion coupling in sympathoadrenal chromaffin cells
  publication-title: Neuropharmacology
– volume: 60
  start-page: 3208
  issue: 12
  year: 2011
  end-page: 3216
  article-title: Convergence of the insulin and serotonin programs in the pancreatic β-cell
  publication-title: Diabetes
– volume: 7
  start-page: 648
  issue: 6
  year: 2007
  end-page: 652
  article-title: The leptin hypothesis of depression: a potential link between mood disorders and obesity?
  publication-title: Curr Opin Pharmacol
– volume: 22
  start-page: s176
  issue: 7
  year: 2016
  end-page: s185
  article-title: Obesity: definition, comorbidities, causes, and burden
  publication-title: Am J Manag Care
– volume: 19
  start-page: 154
  issue: 2
  year: 1998
  end-page: 159
  article-title: Presence and characterization of the serotonin transporter in human resting lymphocytes
  publication-title: Neuropsychopharmacology
– volume: 282
  start-page: 1568
  issue: 16
  year: 1999
  end-page: 1575
  article-title: Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial
  publication-title: JAMA
– volume: 6
  start-page: 327
  issue: 3
  year: 1982
  end-page: 333
  article-title: Serotonin uptake by blood platelets of schizophrenic patients
  publication-title: Psychiatry Res
– volume: 33
  start-page: 673
  issue: 7
  year: 2015
  end-page: 689
  article-title: The epidemiology of obesity: a big picture
  publication-title: Pharmacoeconomics
– volume: 19
  start-page: 293
  issue: 4
  year: 2014
  end-page: 304
  article-title: Metabolic syndrome and major depression
  publication-title: CNS Spectr
– volume: 281
  start-page: 24769
  issue: 34
  year: 2006
  end-page: 24780
  article-title: Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter
  publication-title: J Biol Chem
– volume: 131
  start-page: 61
  issue: 1
  year: 2011
  end-page: 79
  article-title: Ontogeny and regulation of the serotonin transporter: providing insights into human disorders
  publication-title: Pharmacol Ther
– volume: 21
  start-page: 309
  issue: 8
  year: 2000
  end-page: 314
  article-title: Leptin as a regulator of adipose mass and reproduction
  publication-title: Trends Pharmacol Sci
– volume: 24
  start-page: 27
  issue: 1
  year: 2009
  end-page: 53
  article-title: The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression
  publication-title: Metab Brain Dis
– volume: 334
  start-page: 292
  issue: 5
  year: 1996
  end-page: 295
  article-title: Serum immunoreactive-leptin concentrations in normal-weight and obese humans
  publication-title: N Engl J Med
– volume: 63
  start-page: 182
  issue: 3
  year: 2017
  end-page: 190
  article-title: Psychiatric disorders and obesity: a review of association studies
  publication-title: J Postgrad Med
– volume: 2017
  start-page: 1
  issue: 288
  year: 2016
  end-page: 8
  article-title: Prevalence of obesity among adults and youth: United States 2015–2016
  publication-title: NCHS Data Brief
– volume: 10
  start-page: 158
  year: 2019
  article-title: Tryptophan metabolic pathways and brain serotonergic activity: a comparative review
  publication-title: Front Endocrinol (Lausanne)
– volume: 77
  start-page: 230
  issue: 4
  year: 2019
  end-page: 239
  article-title: Adherence to the Mediterranean diet and risk of depression: a systematic review and updated meta-analysis of observational studies [published correction appears in Nutr Rev. 2019;77(6):454]
  publication-title: Nutr Rev
– volume: 109
  start-page: 73
  year: 2014
  end-page: 82
  article-title: Neuroendocrinology of obesity
  publication-title: Br Med Bull
– volume: 13
  start-page: 551
  issue: 6
  year: 2011
  end-page: 558
  article-title: Adipocytes express a functional system for serotonin synthesis, reuptake and receptor activation
  publication-title: Diabetes Obes Metab
– volume: 35
  start-page: 628
  issue: 4
  year: 2010
  end-page: 635
  article-title: Human serotonin transporter expression during megakaryocytic differentiation of MEG-01 cells
  publication-title: Neurochem Res
– volume: 967
  start-page: 379
  year: 2002
  end-page: 388
  article-title: Leptin signaling, adiposity, and energy balance
  publication-title: Ann N Y Acad Sci
– volume: 589
  start-page: 1728
  issue: 15
  year: 2015
  end-page: 1734
  article-title: The roles of peripheral serotonin in metabolic homeostasis
  publication-title: FEBS Lett
– volume: 16
  start-page: 533
  issue: 5
  year: 2018
  end-page: 558
  article-title: Imaging the role of inflammation in mood and anxiety-related disorders
  publication-title: Curr Neuropharmacol
– volume: 11
  start-page: 493
  year: 2017
  article-title: The energy metabolism dysfunction in psychiatric disorders postmortem brains: focus on proteomic evidence
  publication-title: Front Neurosci
– volume: 7
  start-page: 499
  issue: 1–4
  year: 1987
  end-page: 521
  article-title: Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression
  publication-title: J Recept Res
– volume: 2010
  start-page: 748048
  year: 2010
  article-title: The role of adipokines in understanding the associations between obesity and depression
  publication-title: J Obes
– volume: 12
  start-page: 18
  year: 2011
  article-title: Serotonin transporter (SERT) and translocator protein (TSPO) expression in the obese ob/ob mouse
  publication-title: BMC Neurosci
– volume: 14
  start-page: 522
  issue: 5
  year: 2013
  end-page: 530
  article-title: The role of platelet/lymphocyte serotonin transporter in depression and beyond
  publication-title: Curr Drug Targets
– volume: 158
  start-page: 1049
  issue: 5
  year: 2017
  end-page: 1063
  article-title: The diverse metabolic roles of peripheral serotonin
  publication-title: Endocrinology
– volume: 70
  start-page: 703
  year: 2019
  end-page: 718
  article-title: Stress and obesity
  publication-title: Annu Rev Psychol
– volume: 8
  start-page: e78241
  issue: 11
  year: 2013
  article-title: Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype
  publication-title: PLoS One
– volume: 271
  start-page: 16494
  issue: 28
  year: 1996
  end-page: 16499
  article-title: Stimulation of mitogen-activated protein kinase and Na+/H+ exchanger in human platelets. Differential effect of phorbol ester and vasopressin
  publication-title: J Biol Chem
– volume: 101
  start-page: 1423
  issue: 10
  year: 2009
  end-page: 1426
  article-title: Glycaemic status in relation to oxidative stress and inflammation in well-controlled type 2 diabetes subjects
  publication-title: Br J Nutr
– volume: 511
  start-page: 84
  issue: 2
  year: 2012
  end-page: 88
  article-title: Selective serotonin receptor stimulation of the medial nucleus accumbens differentially affects appetitive motivation for food on a progressive ratio schedule of reinforcement
  publication-title: Neurosci Lett
– volume: 13
  start-page: 145
  issue: 1–2
  year: 1990
  end-page: 154
  article-title: Seasonal serotonin uptake changes in healthy subjects
  publication-title: Mol Chem Neuropathol
– volume: 34
  start-page: 509
  issue: 5
  year: 1977
  end-page: 516
  article-title: The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders
  publication-title: Arch Gen Psychiatry
– volume: 390
  start-page: 1345
  issue: 10100
  year: 2017
  end-page: 1422
  article-title: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [published correction appears in Lancet. 2017;390(10104):1736] [published correction appears in Lancet. 2017;390(10106):e38]
  publication-title: Lancet
– volume: 103
  start-page: 125
  issue: 2–3
  year: 2001
  end-page: 131
  article-title: Decreased platelet [3H]paroxetine binding sites in suicide attempters
  publication-title: Psychiatry Res
– volume: 600
  start-page: 521
  year: 1990
  end-page: 531
  article-title: Serotonin and appetite
  publication-title: Ann N Y Acad Sci
– volume: 15
  start-page: 37
  issue: 1
  year: 2011
  end-page: 46
  article-title: Reward, dopamine and the control of food intake: implications for obesity
  publication-title: Trends Cogn Sci
– volume: 22
  start-page: 307
  issue: 5
  year: 2014
  end-page: 320
  article-title: Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: a literature review
  publication-title: Eur Eat Disord Rev
– volume: 45
  start-page: 419
  issue: 3
  year: 2013
  end-page: 430
  article-title: Large neutral amino acids: dietary effects on brain neurochemistry and function
  publication-title: Amino Acids
– volume: 8
  start-page: 222
  issue: 4
  year: 2011
  end-page: 232
  article-title: HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
  publication-title: Nat Rev Cardiol
– volume: 208
  start-page: 41
  issue: 1
  year: 2011
  end-page: 52
  article-title: Leptin-dependent serotonin control of appetite: temporal specificity, transcriptional regulation, and therapeutic implications
  publication-title: J Exp Med
– volume: 24
  start-page: 1978
  issue: 10
  year: 2010
  end-page: 1987
  article-title: Regulation of adipocyte differentiation by activation of serotonin (5-HT) receptors 5-HT2AR and 5-HT2CR and involvement of microRNA-448-mediated repression of KLF5
  publication-title: Mol Endocrinol
– volume: 14
  start-page: 135
  year: 2013
  end-page: 151
  article-title: Inflammation and depression
  publication-title: Curr Top Behav Neurosci
– volume: 277
  start-page: 14
  year: 2015
  end-page: 31
  article-title: Serotonin controlling feeding and satiety
  publication-title: Behav Brain Res
– volume: 220
  start-page: 11
  issue: 1
  year: 2012
  end-page: 21
  article-title: Emerging role of high-density lipoproteins as a player in the immune system
  publication-title: Atherosclerosis
– volume: 52
  start-page: 284
  issue: 1
  year: 2010
  end-page: 289
  article-title: Cerebral serotonin transporter binding is inversely related to body mass index
  publication-title: Neuroimage
– volume: 11
  start-page: 277
  year: 2017
  article-title: Serotonergic control of metabolic homeostasis
  publication-title: Front Cell Neurosci
– volume: 22
  start-page: 382
  issue: 9
  year: 2011
  end-page: 387
  article-title: Towards a serotonin-dependent leptin roadmap in the brain
  publication-title: Trends Endocrinol Metab
– volume: 50
  start-page: 11
  issue: 1
  year: 1998
  end-page: 15
  article-title: Effect of aging and sex on the [3H]-paroxetine binding to human platelets
  publication-title: J Affect Disord
– volume: 60
  start-page: 2319
  issue: 6
  year: 1993
  end-page: 2322
  article-title: Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter
  publication-title: J Neurochem
– volume: 587
  start-page: 49
  issue: 1
  year: 2009
  end-page: 60
  article-title: Pharmacological targeting of the serotonergic system for the treatment of obesity
  publication-title: J Physiol
– volume: 668
  start-page: S10
  issue: 1
  year: 2011
  end-page: 15
  article-title: Non-nutritional uses of nutrients
  publication-title: Eur J Pharmacol
– volume: 265
  start-page: 567
  year: 2020
  end-page: 569
  article-title: Improving diet for psychiatric patients: High potential benefits and evidence for safety
  publication-title: J Affect Disord
– volume: 4
  start-page: 70
  issue: 2
  year: 2008
  end-page: 79
  article-title: Leptin and inflammation
  publication-title: Curr Immunol Rev.
– volume: 73
  start-page: 827
  issue: 9
  year: 2013
  end-page: 835
  article-title: Stress as a common risk factor for obesity and addiction
  publication-title: Biol Psychiatry
– volume: 14
  start-page: 213
  issue: 3
  year: 1985
  end-page: 228
  article-title: Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC
  publication-title: J Pharmacol Methods
– volume: 12
  start-page: e0187448
  issue: 11
  year: 2017
  article-title: The association between depressive symptoms and insulin resistance, inflammation and adiposity in men and women
  publication-title: PLoS One
– volume: 4
  start-page: 363
  issue: 3
  year: 2015
  end-page: 370
  article-title: Overweight and obesity: prevalence, consequences, and causes of a growing public health problem
  publication-title: Curr Obes Rep
– volume: 34
  start-page: 184
  issue: 4
  year: 1996
  end-page: 187
  article-title: Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients
  publication-title: Neuropsychobiology
– volume: 81
  start-page: 807
  issue: 9
  year: 2017
  end-page: 814
  article-title: Leptin dysregulation is specifically associated with major depression with atypical features: evidence for a mechanism connecting obesity and depression
  publication-title: Biol Psychiatry
– volume: 7
  start-page: 207
  issue: 2
  year: 2013
  end-page: 222
  article-title: Leptin signaling and leptin resistance
  publication-title: Front Med
– ident: S1092852920001820_r62
  doi: 10.1056/NEJM199602013340503
– ident: S1092852920001820_r32
  doi: 10.1007/s11064-009-0112-8
– ident: S1092852920001820_r3
  doi: 10.1016/S0140-6736(17)32366-8
– ident: S1092852920001820_r74
  doi: 10.1111/apha.13101
– ident: S1092852920001820_r46
  doi: 10.1093/nutrit/nuy070
– ident: S1092852920001820_r54
  doi: 10.1007/7854_2012_211
– ident: S1092852920001820_r7
  doi: 10.1007/s40273-014-0243-x
– ident: S1092852920001820_r12
  doi: 10.1210/en.2016-1839
– ident: S1092852920001820_r36
  doi: 10.1016/0160-5402(85)90034-8
– ident: S1092852920001820_r42
  doi: 10.1016/j.neuropharm.2016.08.015
– ident: S1092852920001820_r28
  doi: 10.1016/S0165-1781(01)00281-5
– ident: S1092852920001820_r49
  doi: 10.1038/nrcardio.2010.222
– ident: S1092852920001820_r26
  doi: 10.3109/10799898709054999
– ident: S1092852920001820_r11
  doi: 10.1186/1471-2202-14-128
– ident: S1092852920001820_r38
  doi: 10.1172/JCI70338
– ident: S1092852920001820_r27
  doi: 10.1159/000119308
– ident: S1092852920001820_r51
  doi: 10.1016/j.atherosclerosis.2011.06.045
– ident: S1092852920001820_r35
  doi: 10.1016/0165-1781(82)90022-1
– volume: 22
  start-page: s176
  year: 2016
  ident: S1092852920001820_r2
  article-title: Obesity: definition, comorbidities, causes, and burden
  publication-title: Am J Manag Care
  contributor:
    fullname: Apovian
– ident: S1092852920001820_r9
  doi: 10.1093/bmb/ldu001
– ident: S1092852920001820_r67
  doi: 10.1146/annurev-psych-010418-102936
– ident: S1092852920001820_r72
  doi: 10.1016/j.coph.2007.10.010
– ident: S1092852920001820_r70
  doi: 10.1371/journal.pbio.1000229
– ident: S1092852920001820_r22
  doi: 10.1002/erv.2303
– ident: S1092852920001820_r63
  doi: 10.1001/jama.282.16.1568
– ident: S1092852920001820_r21
  doi: 10.1084/jem.20101940
– ident: S1092852920001820_r59
  doi: 10.1016/S0165-6147(00)01514-5
– ident: S1092852920001820_r18
  doi: 10.1111/j.1463-1326.2011.01378.x
– ident: S1092852920001820_r47
  doi: 10.1016/j.neuroimage.2010.03.086
– ident: S1092852920001820_r64
  doi: 10.1007/s11684-013-0263-5
– ident: S1092852920001820_r15
  doi: 10.1016/j.nutres.2012.03.009
– ident: S1092852920001820_r40
  doi: 10.3389/fendo.2019.00158
– ident: S1092852920001820_r16
  doi: 10.3389/fncel.2017.00277
– ident: S1092852920001820_r53
  doi: 10.1007/s11011-008-9118-1
– ident: S1092852920001820_r61
  doi: 10.1186/1471-2202-12-18
– ident: S1092852920001820_r23
  doi: 10.1001/archpsyc.1977.01770170019001
– ident: S1092852920001820_r39
  doi: 10.1113/jphysiol.2008.164152
– ident: S1092852920001820_r56
  doi: 10.3389/fnins.2017.00493
– ident: S1092852920001820_r19
  doi: 10.1017/S1092852913000667
– ident: S1092852920001820_r58
  doi: 10.1155/2010/748048
– ident: S1092852920001820_r30
  doi: 10.1074/jbc.271.28.16494
– ident: S1092852920001820_r6
– ident: S1092852920001820_r50
  doi: 10.1017/S0007114508076204
– ident: S1092852920001820_r66
  doi: 10.1016/j.biopsych.2013.01.032
– ident: S1092852920001820_r1
  doi: 10.1007/s13679-015-0169-4
– ident: S1092852920001820_r14
  doi: 10.1007/s00726-012-1330-y
– ident: S1092852920001820_r10
  doi: 10.1016/j.bbr.2014.08.065
– ident: S1092852920001820_r52
  doi: 10.1371/journal.pone.0078241
– ident: S1092852920001820_r31
  doi: 10.1074/jbc.M603877200
– ident: S1092852920001820_r34
  doi: 10.1007/BF03159915
– ident: S1092852920001820_r69
  doi: 10.2337/db10-1192
– ident: S1092852920001820_r20
  doi: 10.1016/j.tem.2011.04.006
– ident: S1092852920001820_r73
  doi: 10.1210/er.2018-00283
– ident: S1092852920001820_r65
  doi: 10.1016/j.biopsych.2015.10.023
– ident: S1092852920001820_r25
  doi: 10.1111/j.1471-4159.1993.tb03522.x
– volume-title: Structured Clinical Interview for DSM-IV Axis I Disorders—Clinican Version (SCID-CV)
  year: 1997
  ident: S1092852920001820_r33
  contributor:
    fullname: First
– ident: S1092852920001820_r24
  doi: 10.1016/S0893-133X(97)00204-2
– ident: S1092852920001820_r17
  doi: 10.1210/me.2010-0054
– ident: S1092852920001820_r60
  doi: 10.1111/j.1749-6632.2002.tb04293.x
– ident: S1092852920001820_r5
– ident: S1092852920001820_r29
  doi: 10.2174/1389450111314050003
– ident: S1092852920001820_r8
  doi: 10.1016/j.tics.2010.11.001
– ident: S1092852920001820_r43
  doi: 10.1016/j.febslet.2015.05.054
– ident: S1092852920001820_r55
  doi: 10.2174/1570159X15666171123201142
– volume: 2017
  start-page: 1
  year: 2016
  ident: S1092852920001820_r4
  article-title: Prevalence of obesity among adults and youth: United States 2015–2016
  publication-title: NCHS Data Brief
  contributor:
    fullname: Hales
– ident: S1092852920001820_r57
  doi: 10.2174/157339508784325046
– volume: 63
  start-page: 182
  year: 2017
  ident: S1092852920001820_r48
  article-title: Psychiatric disorders and obesity: a review of association studies
  publication-title: J Postgrad Med
  doi: 10.4103/jpgm.JPGM_712_16
  contributor:
    fullname: Rajan
– ident: S1092852920001820_r37
  doi: 10.1111/j.1749-6632.1990.tb16907.x
– ident: S1092852920001820_r41
  doi: 10.1016/j.pharmthera.2011.03.013
– ident: S1092852920001820_r45
  doi: 10.1016/j.jad.2019.11.092
– ident: S1092852920001820_r68
  doi: 10.1016/j.neulet.2012.01.038
– ident: S1092852920001820_r44
  doi: 10.1016/S0165-0327(97)00074-8
– ident: S1092852920001820_r13
  doi: 10.1016/j.ejphar.2011.07.005
– ident: S1092852920001820_r71
  doi: 10.1371/journal.pone.0187448
SSID ssj0043783
Score 2.389206
Snippet To provide evidence to the link between serotonin (5-HT), energy metabolism, and the human obese phenotype, the present study investigated the binding and...
Abstract Objective To provide evidence to the link between serotonin (5-HT), energy metabolism, and the human obese phenotype, the present study investigated...
ObjectiveTo provide evidence to the link between serotonin (5-HT), energy metabolism, and the human obese phenotype, the present study investigated the binding...
SourceID proquest
crossref
pubmed
cambridge
SourceType Aggregation Database
Index Database
Publisher
StartPage 99
SubjectTerms Adipocytes
Blood platelets
Body mass index
Cholesterol
Drug withdrawal
Drugs
Eating disorders
Endocrinology
Gene expression
Glucose
High density lipoprotein
Hormones
Insulin
Kinases
Mental disorders
Metabolic syndrome
Obesity
Original Research
Overweight
Peptides
Proteins
Serotonin
Signal transduction
Weight control
Title The complex interactions among serotonin, insulin, leptin, and glycolipid metabolic parameters in human obesity
URI https://www.cambridge.org/core/product/identifier/S1092852920001820/type/journal_article
https://www.ncbi.nlm.nih.gov/pubmed/32921339
https://www.proquest.com/docview/2754984718
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA-6gfgifjudIw8-yYpd2jTtk6hsDGFDxMHeSpKmMtjauVbQ_967fmyK6FMhNHm4u1zukt_9jpArqW1kTXOtIOoZyxVSW1JxZfmRiZmnwD0aLE4ejb3hxH2c8ml14ZZVsMraJxaOOko13pHfMAGZTOFKb5dvFnaNwtfVqoXGNmn2mO0hpEtM1wmX6wi_BNgHsOs5C-pXTaSMxkEcw1IVJDH_zq3w84z6I_AsDqDBPtmrIkd6V6r6gGyZ5JDsjKq38SOSgsZpgRA3HxRZIFZlzUJGi4ZCFGwtzfHytUsrAHqXzhHTAl-ZRPR1_glGMVvOIrowOdjGfKYpMoMvEDGTwSRaNPSjadlL4JhMBv2Xh6FVtVOwtCOc3HJ0ILEwVooo5hpSXzz_456SLsQgDshBepJLpTzHDoyOJNdKaC8Q0tcKfrKdE9JI0sScEWo0s7X2fM1iyF_A6fGYSx55mkvBOJMt0l0LM6w2RRaWgDIR_pJ9i1zX8g6XJcnGfz-3a41slt5YR4ucllpar-TAXMjEg_P_J16QXYalDQUiu00a-erdXELAkatOYVUd0rzvj5-evwBixNKd
link.rule.ids 315,783,787,12068,21400,27936,27937,31731,33756,43322,43817,74073,74630
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwEA66gfoi_nY6NQ8-yYpb2zTrk6hMpm5DZIO9lSRNZbC1c6ug_713bbop4p4KocnD3eVyl3z3HSGXQtWRNc21_LChLZcLZQnJpNUMdWR7EtyjxuLkbs9rD9ynIRuaC7e5gVUWPjFz1GGi8I782uaQyWSu9Gb6bmHXKHxdNS001kkZqaog-SrftXovr4Uvdh3ezCH2Pux7ZvvFuyaSRuMgjmGxCtKY_2RX-H1K_RN6ZkfQww7ZNrEjvc2VvUvWdLxHNrrmdXyfJKBzmmHE9SdFHohZXrUwp1lLIQrWlqR4_VqjBoJeo2NEtcBXxCF9G3-BWYymo5BOdArWMR4pitzgE8TMzGESzVr60STvJnBABg-t_n3bMg0VLOVwJ7Uc5QssjRU8jJiC5BcjgKghhQtRiANyEJ5gQkrPqftahYIpyZXnc9FUEn6qO4ekFCexPiZUK7uulNdUdgQZDLg9FjHBQk8xwW1miwqpLYQZmG0xD3JIGQ_-yL5Crgp5B9OcZmPVz9VCI8ull_ZRIUe5lhYrOTAXcnH_ZPXEC7LZ7nc7Qeex93xKtmwsdMjw2VVSSmcf-gzCj1SeGxv7BnO11Vk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED90g-GL-O10ah58khVn2zTrk_g15tcYorC3kqSpDOY6XQX9771rU6eIeyqEJA9311_ukt_dARxK3aKqab4TxifG8YXUjlRcOe3YJG6gEB4NJSff94Luk38z4APLf5paWmWJiTlQx6mmO_JjV2Akk0PpcWJpEf3Lzunk1aEOUvTSattpLEJV-IHXqkD1_KrXfyhx2fdEu6Dbh4gB3A3LN04qIE2DNEaJK1TS_Gelhd8n1j9uaH4cdVZg2fqR7KxQ_CosmPEa1O7tS_k6pKh_lvPFzQejmhBvRQbDlOXthRhaXprRVWyTWTp6k42I4YJfOY7Z8-gTTWQ4GcbsxWRoKaOhZlQn_IX4M1NcxPL2fiwtOgtswFPn6vGi69jmCo72hJc5ng4lpclKESdcYyBM3kByoqSPHomHcpCB5FIplGRodCy5VkIHoZBtrXBSy9uEyjgdm21gRrstrYO2dhOMZhACecIljwPNpXC5K-vQ_BZmZH-RaVTQy0T0R_Z1OCrlHU2KkhvzJjdKjcy2ntlKHbYKLX3v5OFajMvDnfkLD6CG5hXdXfdud2HJpZyHnKrdgEr29m720BPJ1L41sS9-etmH
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+complex+interactions+among+serotonin%2C+insulin%2C+leptin%2C+and+glycolipid+metabolic+parameters+in+human+obesity&rft.jtitle=CNS+spectrums&rft.au=Marazziti%2C+Donatella&rft.au=Betti%2C+Laura&rft.au=Baroni%2C+Stefano&rft.au=Palego%2C+Lionella&rft.date=2022-02-01&rft.pub=Cambridge+University+Press&rft.issn=1092-8529&rft.volume=27&rft.issue=1&rft.spage=99&rft.epage=108&rft_id=info:doi/10.1017%2FS1092852920001820&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1092-8529&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1092-8529&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1092-8529&client=summon